🇺🇸 FDA
Patent

US 7098216

Thiazolopyrimidines useful as TNFα inhibitors

granted A61PA61P1/00A61P11/06

Quick answer

US patent 7098216 (Thiazolopyrimidines useful as TNFα inhibitors) held by The Regents of the University of California expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P11/06, A61P17/06, A61P19/02